Novavax COVID-19 Vaccine Could Be Approved Very Soon, Says EMA Chief

BRUSSELS — The head of the European Medicines Agency (EMA) on Tuesday said that it could soon approve the COVID-19 vaccine developed by U.S. biotech company Novavax. Read More